Q3694905 (Q3694905): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy., translated_summary) |
||||||||||||||
Property / summary | |||||||||||||||
The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English) | |||||||||||||||
Property / summary: The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English) / qualifier | |||||||||||||||
point in time: 22 November 2021
|
Revision as of 10:27, 22 November 2021
Project Q3694905 in France
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q3694905 in France |
Statements
187,989.0 Euro
0 references
457,614.57 Euro
0 references
41.08 percent
0 references
30 March 2015
0 references
30 September 2017
0 references
Université de Bourgogne
0 references
Le développement de nouveaux médicaments est un processus de plus en plus coûteux et compliqué sur le plan réglementaire comme technique; l’imagerie médicale dans ce contexte représente un axe stratégique pour l’économie. (French)
0 references
The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English)
22 November 2021
0 references
Identifiers
BG0003226
0 references